|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.700 CHF | +7.77% |
|
+5.05% | +29.41% |
| 03/06 | Pharmacy fee hike to be implemented in two stages | DP |
| 22/05 | New services in pharmacies - what is in store for patients | DP |
Company Valuation: DocMorris AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,412 | 320.6 | 860.2 | 257.7 | 289.2 | 373.4 | - | - |
| Change | - | -86.71% | 168.32% | -70.05% | 12.22% | 29.14% | - | - |
| Enterprise Value (EV) 1 | 2,714 | 723.2 | 1,137 | 486.1 | 426.8 | 575.2 | 614.1 | 629.3 |
| Change | - | -73.36% | 57.22% | -57.25% | -12.21% | 34.79% | 6.76% | 2.48% |
| P/E Ratio | -10.1x | -1.61x | 10.5x | -2.42x | -1.71x | -4.83x | -8.69x | -22.2x |
| PBR | 5.44x | 0.84x | 2.01x | 0.69x | 0.7x | 1.19x | 1.2x | 1.42x |
| PEG | - | 0.1x | -0x | 0x | 0x | 0.1x | 0.2x | 0.4x |
| Capitalization / Revenue | 1.4x | 0.2x | 0.89x | 0.25x | 0.26x | 0.31x | 0.27x | 0.26x |
| EV / Revenue | 1.57x | 0.45x | 1.18x | 0.48x | 0.38x | 0.47x | 0.45x | 0.43x |
| EV / EBITDA | -19x | -9.31x | -29.6x | -10x | -8.85x | -32.3x | 42.5x | 14.8x |
| EV / EBIT | -14x | -5.15x | -13.7x | -5.41x | -4.41x | -8.62x | -17.4x | -63.4x |
| EV / FCF | -14x | -3.87x | -9.88x | -8.81x | -3.68x | -8.04x | -17.8x | -34.3x |
| FCF Yield | -7.15% | -25.9% | -10.1% | -11.4% | -27.2% | -12.4% | -5.62% | -2.92% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.4 | -15.88 | 7.05 | -8.25 | -3.47 | -1.595 | -0.8866 | -0.3464 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,726 | 1,608 | 966.9 | 1,017 | 1,124 | 1,218 | 1,369 | 1,463 |
| EBITDA 1 | -142.6 | -77.7 | -38.4 | -48.6 | -48.24 | -17.79 | 14.46 | 42.56 |
| EBIT 1 | -193.8 | -140.3 | -83.2 | -89.8 | -96.86 | -66.73 | -35.38 | -9.926 |
| Net income 1 | -225.7 | -171.1 | 82.2 | -97.3 | -134.4 | -84.15 | -48.29 | -23.38 |
| Net Debt 1 | 302.8 | 402.6 | 276.8 | 228.4 | 137.6 | 201.8 | 240.7 | 255.9 |
| Reference price 2 | 235.500 | 25.560 | 73.750 | 19.980 | 5.950 | 7.700 | 7.700 | 7.700 |
| Nbr of stocks (in thousands) | 10,240 | 12,543 | 11,664 | 12,897 | 48,599 | 48,496 | - | - |
| Announcement Date | 24/03/22 | 24/03/23 | 20/03/24 | 12/03/25 | 18/03/26 | - | - | - |
1CHF in Million2CHF
Estimates
P/E Ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.48x | 0.45x | -30.82x | -.--% | 43Cr | |
| 18.08x | 0.76x | 11.93x | -.--% | 1.56TCr | |
| 21.53x | 1.07x | 16.55x | -.--% | 717.81Cr | |
| 16.76x | 0.73x | 7.61x | 2.03% | 585.38Cr | |
| 13.33x | 0.85x | 6.14x | 3.22% | 378.12Cr | |
| 16.19x | 0.99x | 7.36x | 3.99% | 333.22Cr | |
| 14.77x | 1.25x | 7.59x | 5.6% | 330.21Cr | |
| 12.62x | 0.51x | 4.05x | 5.36% | 276.51Cr | |
| 40.95x | - | - | - | 265.76Cr | |
| Average | 16.64x | 0.83x | 3.80x | 2.52% | 498.5Cr | |
| Weighted average by Cap. | 18.48x | 0.85x | 9.94x | 1.67% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DOCM Stock
- Valuation DocMorris AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition